Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-852-3 | CAS number: 111-27-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
The key acute oral toxicity study, conducted according to a guideline similar to the now-deleted OECD Test Guideline 401 but prior to GLP compliance, reports an LD50 value of 3210 mg/kg in rat (Scientific Associates Inc 1965).
The key acute inhalation toxicity study, which was conducted prior to OECD Test Guidelines and GLP, reports an LC50 value of >21 mg/L air (mist) (Scientific Associates Inc. 1977).
The key acute dermal toxicity study, conducted according to a guideline similar to OECD Test Guideline 402 but prior to GLP compliance, reports a LD50 value of 1500-2000 mg/kg bw in rabbit, which is a combined value for intact and abraded skin (Scientific Associates Inc. 1977).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- other: LD50
- Limit test:
- no
- Species:
- rat
- Strain:
- other: Holtzman albino
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 200-265g
- Fasting period before study: Over night
- Housing: Group housing (5 of each sex per cage), in metal cages provided with white pine and cheddar shavings.
- Diet: Purina Laboratory Chow, ad libitum.
- Water: ad libitum
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: Exploratory doses were administered to 8 rats to estimate the order of toxicity of the test compound. Based on the preliminary estimation, groups of 10 rats (5M, 5F) were administered the test compound at graded dosage levels designed to blanket the toxicity range. - Doses:
- 1.17, 1.65, 2.33, 3.28, 4.64 and 6.55 gm/kg
- No. of animals per sex per dose:
- 5 female, 5 male
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Regular intervals on the day of dosing and daily thereafter for 14 days.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: Gross necropsies were performed on all survivors and any animals which died during the observation period. Body weights of survivors were recorded prior to sacrifice. - Statistics:
- Confidence Interval 2.85 ml (2.35 gm) to 5.34ml (4.39gm)/kg body weight. Slope function 1.88, with confidence interval of 1.26 to 2.80.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 3 210 mg/kg bw
- Mortality:
- All deaths occurred within 24 hours of dosing. See table.
. - Clinical signs:
- other: Animals at all dose levels exhibited weakness and ataxia. They became comatose and breathing was laboured while comatose. Animals which survived appeared normal within 24 hours other than top dose animals (6.55 g/kg) where the rats appeared unwell up t
- Gross pathology:
- Necropsy of animals which died showed congestion of the lungs and adrenals in most animals. In some cases gastric
congestion was also observed. There were no remarkable gross findings in animals sacrificed at the end of the observation period. - Other findings:
- - Organ weights: Not recorded
- Histopathology: Not available
- Potential target organs: No conclusion drawn
- Other observations: No sex specific differences were reported, mortality represented as a combined value so no independent assesment can be made.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute oral toxicity study for hexan-1-ol, conducted according to a guideline similar to the now-deleted OECD Test Guideline 401 but prior to GLP compliance, reports an LD50 value of 3210 mg/kg in rat.
Reference
Table 1: Number of animals dead within the 14 day study period.
Dose |
Mortality (# dead/total) |
Time of death (day) |
||
Male |
Female |
Combined |
||
1.42 (1.17) |
|
|
0/10 |
|
2.00 (1.65) |
|
|
1/10 |
1 |
2.83 (2.33) |
|
|
4/10 |
1 |
3.99 (3.28) |
|
410 |
1 |
|
5.64 (4.64) |
|
|
8/10 |
1 |
7.96 (6.55) |
|
|
8/10 |
1 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 210 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1977
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Only one dose level, short exposure period, no indication of droplet size.
- GLP compliance:
- not specified
- Test type:
- other:
- Limit test:
- no
- Species:
- rat
- Strain:
- other: T23-48:COX-SD
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 245-356g
- Housing: 57 litre capacity glass chamber
- Diet: Purina laboratoy chow (ad libitum)
- Water: yes (ad libitum)
IN-LIFE DATES: Not specified. - Route of administration:
- other: mist
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: atmosphere generated as a mist
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Devilbiss Nebulizer
- Exposure chamber volume: 57 litres
- Method of holding animals in test chamber: Free to move in the glass chamber
- Source and rate of air: Delivery flow concentration of approximately 21 mg per litre of air, at a flow rate of six litres per minute.
TEST ATMOSPHERE
- Brief description of analytical method used: Prior to the actual exposure period, the test material was introduced into the chambre for ten minutes in order to make sure the test atmospheric concetration could reach theoretical equilibrium.
- Samples taken from breathing zone: no
TEST ATMOSPHERE (if not tabulated)
- Particle size distribution: Droplet size not reported - Analytical verification of test atmosphere concentrations:
- not specified
- Duration of exposure:
- 1 h
- Concentrations:
- 21 mg/l
- No. of animals per sex per dose:
- 5 male, 5 female
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were observed frequently for gross effects during the exposure and daily thereafter for 14 days.
- Necropsy of survivors performed: yes - Statistics:
- No statistical analysis was carried out on the test results.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 21 mg/L air
- Exp. duration:
- 1 h
- Mortality:
- All animals survived the 14 day observation period.
- Clinical signs:
- other: During exposure all animals showed hypoactivity and/or ataxia, lethargy and prostration. However within 2 hours of removal from the exposure chamber the animals all appeared and continued to appear normal throughout the observation period.
- Body weight:
- Final bodyweights showed a slight weight loss in one animal however the others all exhibited weight gains within expected limits.
- Gross pathology:
- Gross necropsy revealed moderate pulmonary, adrenal and hepatic congestion in one animal only. The findings in the remaining 9 test animals were unremarkable.
- Other findings:
- No potential target organs were identified.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute inhalation toxicity study, which was conducted prior to OECD Test Guidelines and GLP, reports an LC50 value of >21 mg/L air (mist) following 1-hour whole body inhalation exposure. Since the test atmospheric concentration would in all probablility exceed that to be encountered by humans when the substance is used, hexan-1-ol was found not to be a toxic substance.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 21 mg/m³ air
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1977
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- not specified
- Test type:
- other: LD50
- Limit test:
- no
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 2.3 to 2.9 kg - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- - test material was applied to intact and abraded skin.
- Duration of exposure:
- 24 hours
- Doses:
- 0.5, 1, 1.5 and 2 g/kg
- No. of animals per sex per dose:
- 2M, 2F
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were observed for clinical signs of intoxication several time during the day of dosing and daily thereafter throughout the 14 day observation period. The animals were weighed at sacrifice.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 1 500 - < 2 000 mg/kg bw
- Mortality:
- - Time of death: Within 48 hours of dosing.
- Number of deaths at each dose: 0/4, 1F/4, 1M/4, 4/4. - Clinical signs:
- other: Prior to death generalised weakness and/or unthriftiness, diarrhoea, hypothermia, pallor, loss of corneal and palepebral reflexes, hunched position, flaccidity, slow shallow repsiration and coma. Similar signs of intoxication but less marked were observed
- Gross pathology:
- Premature decedents showed at gross necropsy, in addition to dermal irritation, severe haemorrhaging and/or bloody, gelatinous infiltration of the subcutis, depletion of fatty tissue, slight accumulation of clear fluid within the peritoneal cavity, moderate congestion of liver and kidneys and severe haemorrhaging and/or blanching of the gastric mucosa. Amongst survivors (10), other than residual skin damage, gross necropsy findings were unremarkable in 7 rabbits. In the remaining 3 rabbits there was a slight to moderate accumulation of clear viscous liquid in the peritoneal cavity and/or a dpeletion of visceral fat and mottling or stippling of the renal cortex.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The acute dermal toxicity study, conducted according to a guideline similar to OECD Test Guideline 402 but prior to GLP compliance, reports a LD50 value of 1500-2000 mg/kg bw in rabbit, which is a combined value for intact and abraded skin
Reference
Rabbit dermal LD50 (24 hour occlusive exposure) 1.5 - 2 g/kg. This is a combined value for intact and abraded skin and males/females.
At 24 hours all animals showed slight to moderate erythema especially of the ventral region. Survivors all showed wrinkling
and/or coriaceousness, hardening and desquamation of the skin which persisted throughout the observation period.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 500 mg/kg bw
Additional information
The key acute oral toxicity study for hexan-1-ol, conducted according to a guideline similar to the now-deleted OECD Test Guideline 401 but prior to GLP compliance, reports an LD50 value of 3210 mg/kg in rat (Scientific Associates Inc 1965). In the study, 5 male and 5 female rats were given single oral (gavage) administration of 1.17, 1.65, 2.33, 3.28, 4.64 and 6.55 gm/kg bw of undiluted hexan-1-ol (CAS 111-27-3). The animals were observed for 14 days following administration. Clinical signs and body weights were recorded regularly. Necropsy was performed at the end of the 14-day observation period. No deaths occurred at 1.17 gm/kg bw group; 1 out of 10, 4 out of 10, 4 out of 10, 8 out of 10 and 8 out of 10 animals died at 1.65, 2.33, 3.28, 4.64 and 6.55 gm/kg bw groups, respectively. All deaths occurred withing 24 hours following test item administration. Clinical signs included weakness and ataxia, all surviving animals appearing normal within 48 hours of dosing. Weight gain amongst survivors was within normal limits. Necropsy of decedents revealed congestion of the lungs and adrenals, as well as gastric congestion in some cases. No remarkable gross findings were observed in animals sacrificed at the end of the observation period.
The result of the key study is supported by a reliability 2 study from Scientific Associates Inc. (1977) which reports the LD50 value of 4420 mg/kg in rat, with clinical signs of hypoactivity, diarrhoea and ataxia, gastric mucosa identified as a potential target organ.
Additionally, several reliability 4 supporting studies report LD50 values of 4000 mg/kg in mouse (Bevan, 2001), 4590 mg/kg in rat (Bevan, 2001), 4870 mg/kg in rat (Bevan, 2001), 3131-3344 mg/kg (species unclear) (IUCLID 2000) and 1950 mg/kg in mouse (RTECS, 2004). Several LD50 values for rat are also reported in IUCLID 2000 ascribed to either Henkel or the Dangerous Properties of Industrial Materials Report between 4000 and 4900 mg/kg.
Further investigation of some data listed in IUCLID 2000 and Sax 'Dangerous Properties of Industrial Materials' has led to a reported LD50 in rat of 720 mg/kg bw (Purchase, 1968). While this is an old study with some methodological and reporting deficiencies, on balance it can be considered reliability 2 data and should be taken into account.
The key acute inhalation toxicity study, which was conducted prior to OECD Test Guidelines and GLP, reports an LC50 value of >21 mg/L air (mist) (Scientific Associates Inc. 1977). In the study 5 male and 5 female rats were exposed for 1 hour via whole body inhalation to the atmosphere generated as mist of hexan-1-ol at concentration of 21 mg/L air. Following exposure, the animals were observed for 14 days. Clinical signs and body weights were recorded on a regular basis. At the end of the 14-day observation period, the animals were subject to necropsy. All animals survived the 14 day observation period. During exposure all animals showed hypoactivity and/or ataxia, lethargy and prostration. However within 2 hours of removal from the exposure chamber the animals all appeared and continued to appear normal throughout the observation period. Final bodyweights showed a slight weight loss in one animal however the others all exhibited weight gains within expected limits. Gross necropsy revealed moderate pulmonary, adrenal and hepatic congestion in one animal only. The findings in the remaining 9 test animals were unremarkable.
Two supporting studies of reliability 4 are also provided, with an 8-hour LC50 which was found to be greater than the substantially saturated vapour concentration (Bevan, 2001) and an LC50 >1060ppm (Opdyke, 1975) with very little experimental detail available.
The key acute dermal toxicity study, conducted according to a guideline similar to OECD Test Guideline 402 but prior to GLP compliance, reports a LD50 value of 1500-2000 mg/kg bw in rabbit, which is a combined value for intact and abraded skin (Scientific Associates Inc. 1977). In the study, 0.5, 1, 1.5 and 2 g/kg bw of undiluted hexan-1-ol were applied onto the intact or abraded skin of 2 male and 2 female rabbits per dose for 24 hours under occlusive dressing. Following exposure, the animals were observed for 14 days. Clinical signs and body weights were recorded on a regular basis. At the end of the 14-day observation period, the animals were subject to necropsy. No mortality occurred at 0.5 g/kg bw; 1 out of 4 animals, 1 out of 4 animals and 4 out of 4 animals died at 1, 1.5 and 2 g/kg bw dose groups, respectively. All deaths occurred within 48 hours. Clinical signs prior to death included (but were not limited to) weakness, diarrhoea, slow shallow respiration and coma. Similar, but less marked signs of intoxication were observed in survivors who appeared normal within 96 hours of dosing. Premature decedents showed severe haemorrhaging and/or bloody, gelatinous infiltration of the subcutis, depletion of fatty tissue, accumulation of fluid within peritoneal cavity and moderate congestion of liver and severe haemorrhaging and/or blanching of the gastric mucosa. In the survivors, 7 of the animals showed no remarkable findings at necropsy, but the remaining 3 had a slight to moderate accumulation of clear viscous fluid in the peritoneal cavity and/or depletion of visceral fat and mottling or strippling of the renal cortex.
A supporting, reliability 2 study by Scientific Associates Inc. (1980) reported a rabbit dermal LD50 value of 2330 mg/kg body weight with clinical signs and necropsy findings similar to the key study. The remaining reliability 4 data reports LD50 values of 2530 mg/kg and >5000 mg/kg (Bevan, 2001; Opdyke, 1975). Other LD50 values reported in IUCLID 2000 were ascribed to either Henkel or the Dangerous Properties of Industrial Materials were within the range of 2530-2500 mg/kg.
As shown above, the key dermal result falls within the classifiable range and would be consistent with CLP classification. This appears to be the most sensitive result from a consistent range ca. 1500-2600 mg/kg. The consistency of findings between the key result and others available suggests the findings of the 1977 study were not aberrant.
A full discussion of the Category and considerations of RAAF Assessment Entities can be found in the Human Health Alcohols C6-24 Category report (PFA, 2016).
Discussion of trends in the Category of C6-24 linear and essentially-linear aliphatic alcohols:
Acute toxicity tests of the linear and essentially linear alcohols do not indicate any potential hazard for acute, dermal or inhalation toxicity. Tests on various substances included in this category are all supportive of these results and do not warrant classification for most of the acute toxicity endpoints under GHS criteria. The majority of the substances are therefore not classified for acute toxicity in accordance with EC Regulation 1272/2008. The only exception to this is hexan-1-ol, which finds that the acute data for the test substance are consistent with acute dermal toxicity category 4 and acute oral toxicity 4 H302, the acute oral toxicity classification is in line with the Annex VI entry.
Justification for classification or non-classification
Based on the available data, hexan-1-ol is classified for acute oral toxicity Category 4, H302 "Harmful if swallowed", in Annex VI of Regulation (EC) No 1272/2008. The available data indicate that classification for acute dermal toxicity Category 4, H312 " Harmful in contact with skin", is required according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)